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Abstract
Background: Arachnoid cyst (AC) fluid has not previously been compared with cerebrospinal fluid (CSF) from the
same patient. ACs are commonly referred to as containing “CSF-like fluid”. The objective of this study was to
characterize AC fluid by clinical chemistry and to compare AC fluid to CSF drawn from the same patient. Such
comparative analysis can shed further light on the mechanisms for filling and sustaining of ACs.
Methods: Cyst fluid from 15 adult patients with unilateral temporal AC (9 female, 6 male, age 22-77y) was
compared with CSF from the same patients by clinical chemical analysis.
Results: AC fluid and CSF had the same osmolarity. There were no significant differences in the concentrations of
sodium, potassium, chloride, calcium, magnesium or glucose. We found significant elevated concentration of
phosphate in AC fluid (0.39 versus 0.35 mmol/L in CSF; p = 0.02), and significantly reduced concentrations of total
protein (0.30 versus 0.41 g/L; p = 0.004), of ferritin (7.8 versus 25.5 ug/L; p = 0.001) and of lactate dehydrogenase
(17.9 versus 35.6 U/L; p = 0.002) in AC fluid relative to CSF.
Conclusions: AC fluid is not identical to CSF. The differential composition of AC fluid relative to CSF supports
secretion or active transport as the mechanism underlying cyst filling. Oncotic pressure gradients or slit-valves as
mechanisms for generating fluid in temporal ACs are not supported by these results.
Background
Arachnoid cysts (AC) are relatively common benign
lesions of the arachnoid, with a reported prevalence as
high as 1.1% in the adult population [1]. Clinical presen-
tations of AC include headache, dizziness, seizures [2]
and dyscognition [3]. They can be found all along the
cranio-spinal axis, but have a marked predisposition for
the temporal fossa [4]. The mechanisms underlying the
formation and filling of arachnoid cysts are not well
understood, but clinical, epidemiological, and laboratory
data indicate that genetic mechanisms are involved in
the formation of arachnoid cysts [5,6]. Three prevailing
theories exist for the filling of the cyst: 1) active secre-
tion of fluid by cells in the cyst wall [7,8], 2) fluid influx
due to an oncotic pressure gradient [9], and 3) trapping
of fluid by a valve mechanism [10]. It is conceivable that
the chemical composition of the AC fluid relative to the
cerebrospinal fluid CSF reflects the mechanism by
which the fluid enters the cyst. If the composition is
identical to CSF a valve mechanism appears likely,
whereas if the filling is caused by oncotic pressure, a
higher concentration of proteins in the cyst fluid com-
pared with CSF would be expected. Likewise, cyst fluid
composition could reflect the mechanism of transport
across the cyst wall, if such a mechanism is involved.
In their study of clinical chemical analysis of cyst fluid
in pediatric patients, Sandberg et al.[ 1 1 ]d e s c r i b e da
similar chemical composition to that of reference CSF
in the majority of patients investigated, but in 14 of 41
(34%) the protein concentrations were elevated above * Correspondence: magnus.berle@student.uib.no
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any medium, provided the original work is properly cited.0.50 g/L in the cyst fluid. Based on these findings, the
authors hypothesized that higher protein content could
contribute to the expansion of the cysts by an oncotic
pressure gradient. We have recently described the up-
regulation of the CSF-secreting cation chloride co-trans-
porter NKCC1 in AC membranes compared with nor-
mal arachnoid [8]. This finding supports fluid secretion
as the main mechanism of fluid accumulation in AC.
The objective of the present study was to analyze the
chemical parameters of AC fluid and compare with CSF
from the same patient, to gain further knowledge of AC
concerning the mechanisms of filling and sustaining of
such cysts.
Methods
Patients
A total of 15 patients (9 female, 6 male, age 22-77) with
unilateral, temporal AC were included. Cyst type and
sidedness are summarized in table 1. Patient 3 had pre-
viously had a chronic subdural hematoma, most prob-
ably caused by the cyst [12]. Patient 4 had undergone
previous surgery for the cyst. The other patients had no
previous history of intracranial hematomas or surgery.
Patients were recruited by written informed consent by
the responsible surgeon. This project was approved by
The Regional Committee for Medical and Health
Research Ethics (REK) of Western Norway (approvals
REK 70.03, NSD 9634 and REK 2009/1885).
Operative technique and fluid sampling
Details for the surgical procedure have previously been
given elsewhere [12-14] but a short description is given
here. All patients were operated with a craniotomy
under general anaesthesia, given as total intravenous
anaesthesia (TIVA) with propofol and remifentanyl.
Vecuronium bromide (Norcuron®) was used as the neu-
romuscular blocking agent. A burr hole was made with
a high-speed drill immediately posterior to the sphenoid
wing in order to gain access to the anterior and most
basal aspects of the middle cranial fossa. The dura and
the underlying cyst membrane were punctured through
the burr-hole with a 23 G, 25 mm long syringe con-
nected to an Optidynamic® spinal fluid manometer
(Mediplast AB, Malmo, Sweden). After pressure equili-
bration and registration, a cyst fluid sample (3 - 5 ml)
was collected using the manometer tube as a siphon.
The sample was immediately transferred to a sterile cen-
trifuge tube for centrifuging and further analytic proces-
sing as described below (sample handling). After this
procedure, a standard craniotomy with a microsurgical
resection and fenestration of the cyst membranes was
performed. Before opening the medial cyst wall and thus
communicating the cyst interior to the basal arachnoid
space/CSF, all cyst fluid was aspirated to avoid cyst fluid
contamination of the CSF.
After opening the medial cyst membrane that covered
the basal structures (the tentorial slit, the oculomotor
nerve, the carotid artery, and the optic nerve), thus
creating communication to the basal cisterns and the
posterior fossa, a CSF-sample was collected with a pre-
cut baby-feeding catheter #6, connected to a 10 ml syr-
inge. The catheter was placed below the tentorium via
the tentorial slit and fluid was aspirated gently from the
posterior fossa. The collected CSF was transferred to
centrifuge tubes and proces s e di na ni d e n t i c a lm a n n e r
to the cyst fluid.
Sample handling
The samples were transferred to polypropylene tubes
(Nunc CryoTube, Thermo-Fischer Scientific, Roskilde,
Denmark) and centrifuged for five min at 450 xgto
remove cells and cell debris. The supernatant was trans-
ferred to new polypropylene tubes and immediately
stored on dry ice prior to long term storage at -80°C.
Such sample handling has previously been demonstrated
to reduce degradation of components and cell lysis,
which may change the composition of the sample [15].
Samples were thawed for analysis at room temperature
and transferred to pre-marked analysis tubes for labora-
tory analysis.
Chemical analysis
The samples were analyzed at Laboratory for Clinical
Biochemistry, Haukeland University Hospital, 5021, Ber-
gen, Norway. The laboratory is accredited by Norwegian
Accreditation (accreditation number “TEST 231”)a sa
Table 1 Characteristics of patients in study with age,
gender, Gallasi-stage [20] and remarks.
Patient Age (yrs),
sex
Side Galassi-stage
[20]
Remarks
1 26, f Left 2
2 43, m Left 2
3 58, f Left 3 Old hematoma
4 34, f Left 2 Reoperation
5 22, f Right 1
6 36, f Right 2 Slight hemolysis
CSF
7 35, f Right 2
8 77, f Left 1
9 42, f Left 1
10 60, m Left 2 Slight hemolysis
CSF
11 56, m Right 2
12 25, m Left 1
13 30, f Left 1
14 37, m Left 2
15 63, m Left 2
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of NS-EN ISO 15189. Clinical chemistry analysis was
performed on a Modular Analytics System by Roche
Diagnostics (Roche Diagnostics GmbH, Mannheim, Ger-
many). The analytical coefficient of variation (CV) is
noted in parenthesis for each analyte; Sodium (CV 1%),
potassium (CV 2%) and chloride (CV 2%), were mea-
sured by ion-selective electrode on an ISE 1800 module.
Magnesium (CV 2.5%), phosphate (CV 3%), calcium
(CV 2%), bilirubin (CV 6%) lactate dehydrogenase
(CV 2.5%), protein (CV 1.8%) glucose (CV 2.5%), trigly-
c e r i d e s( C V3 % )a n di r o n( C V2 % )w e r em e a s u r e db y
photometic assays on a P 800-module. Ferritin (CV 5%)
was measured by an ECLIA (electrochemiluminescence)
immunoassay on an E 170-module. Osmolarity (CV
1.5%) was measured by freeze point depression on a
Fiske Micro-Osmometer (Fiske Associates, Massachu-
setts, USA). Immunoglobulins (CV 2-5%) were mea-
sured by nephelometry with system specific N antisera
to Human Immunoglobulins (Dade Behring Marburg
GmbH, Marburg, Germany) on a BN Pro Spec System
(Siemens Healthcare Diagnostics, Illinois, USA)
Statistical analysis
For each of the thirteen patients without previous
operations or known injuries to the AC, the differences
in concentration between cyst fluid and corresponding
CSF were calculated. A paired T-test was then utilized
to check if the mean ratio was equal to one. Due to
slight hemolysis of two CSF samples (patients 6 and 10),
data from these patients were omitted from the statisti-
cal analyses for lactate dehydrogenase, ferritin and pro-
tein. Two patients (patient 3 and 4) were described
clinically as different from the others, and were com-
pared separately with the thirteen native patients using a
two-sample t-test assuming equal variances. Correlation
between lactate dehydrogenase, ferritin and protein was
determined by correlation analysis as a control against a
possible contamination of the samples with blood.
P-values were calculated utilizing Pearson’sp r o d u c t
moment correlation test. Statistical analysis was per-
formed using the statistics software package R version
2.10.1 (The R foundation for Statistical Computing,
Vienna, Austria).
Results
Chemical analysis of AC fluid and CSF, obtained during
elective surgery for arachnoid cysts from 15 patients,
was performed in a routine hospital laboratory. The
results from the measurements are presented in table 2.
There was no significance difference in osmolarity or
concentrations of sodium, potassium, chloride, calcium,
magnesium or glucose between AC fluid and CSF. The
concentration of phosphate was higher in AC fluid rela-
tive to CSF (0.39 versus 0.35 mmol/L; p =0 . 0 2 ) ,w h i l e
the concentration of total protein (0.30 versus 0.41 g/L;
p = 0.004), lactate dehydrogenase (17.9 versus 35.6 U/L;
p = 0.002) and ferritin (7.8 versus 25.5 ug/L; p = 0.001)
was significantly lower in AC relative to CSF. Bilirubin,
iron, triglycerides and immunoglobulins were below
Table 2 Results of chemical analysis of AC fluid and CSF in the same patients, with units, number of samples in
calculation (n), mean results for AC fluid and CSF with standard error of mean (SEM) and means of AC fluid/CSF ratio.
Unit n Mean AC fluid +/- SEM Mean CSF +/- SEM Mean cyst/CSF
Sodium mmol/L 13 142.23 +/- 2.14 142.08 +/- 2.71 1.00
Potassium mmol/L 13 2.47 +/- 0.04 2.35 +/- 0.07 1.05
Chloride mmol/L 13 121.23 +/- 1.94 120.15 +/- 2.54 1.01
Calcium mmol/L 13 1.07 +/- 0.01 1.03 +/- 0.03 1.04
Magnesium mmol/L 13 1.20 +/-0.01 1.14 +/- 0.03 1.05
Phosphate mmol/L 13 0.39 +/-0.01 0.35 +/- 0.01 1.11*
Glucose mmol/L 13 2.85 +/- 0.09 3.13 +/- 0.11 0.92
Protein g/L 10 0.30 +/-0.03 0.41 +/- 0.04 0.71**
Lactate dehydrogenase U/L 11 17.91 +/- 2.93 35.55 +/- 4.61 0.57**
Ferritin ug/L 11 7.82 +/- 1.00 25.55 +/- 6.20 0.31**
Osmolarity mosmol/L 13 290.15 +/-1.07 290.08 +/- 0.96 1.00
IgG g/L < 1.50 < 1.50
IgA g/L < 0.25 < 0.25
IgM g/L < 0.18 < 0.18
Iron umol/L low low
Triglycerides mmol/L low low
Significance levels are denoted as p < 0.05 (*) and p < 0.01 (**). Data from patients #3 and #4 are excluded as clinical outliers from this table. Data from patients
#6 and #10 were excluded for protein, lactate dehydrogenase and ferritin due to slight hemolysis in the CSF. Patient #12 was excluded from protein
concentration measurement as an extreme statistical outlier.
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identified as an extreme outlier for protein measurement
and was excluded from this analysis.
Correlations were calculated between possible blood
contamination parameters ferritin, lactate dehydrogenase
and protein on the CSF samples without observed blood
contamination (n = 11). The correlation between ferritin
and LD was 0.77 (p = 0.006), ferritin and protein was
0.36 (p = 0.312) and lactate dehydrogenase and protein
was 0.34 (p = 0.34). The protein concentrations in the
cyst fluid from the two clinically different patients
(patient 3 and 4, respectively 6.16 g/L (hematoma) and
3.54 g/L (previous operation)) were significantly elevated
relative to the others (p <1 0
-16).
Discussion
The aim of the present study was to collect information
that may contribute to the understanding of the
mechanism for arachnoid cyst filling. If the cyst were
filled by a simple valve mechanism, which has been
observed in suprasellar cysts, it would be expected that
the composition of the cyst fluid would be identical to
that of CSF. On the other hand, if the filling was caused
by oncotic pressure, one would expect a difference in
osmolarity between the AC fluid and CSF as well as a
higher protein content in the AC. If the underlying
mechanism were active secretion or transport, this
would probably cause a different concentration of
certain molecules or ions depending on the underlying
transport mechanisms. We found an isotonic AC fluid
with a lower protein concentration than in CSF; this is
not consistent with an oncotic pressure filling
mechanism.
Macromolecules such as albumin (67 kDa), ferritin (24
subunits between 19 and 21 kDa, total weight around
450 kDa) and lactate dehydrogenase (tetramer of about
37 kDa, total weight around 140 kDa) would be
expected to pass freely through a slit in the cyst mem-
brane. However, the ratio between cyst fluid and CSF
for these three protein complexes was reduced (depen-
dent on size), from 0.73 for protein (of which 2/3 albu-
min) to 0.31 for ferritin. Our findings are therefore
contradictive of a slit valve mechanism underlying the
filling of temporal AC.
The skewed distribution of phosphate could imply a
selective or active transport of fluid and solutes over the
AC membranes. This is consistent with previous find-
ings of morphological and enzyme ultracytochemical
structures in the wall of arachnoid cysts assumed to be
capable of fluid secretion, as reported by Go et al [7].
Furthermore, our group has recently published evidence
that there are differences between arachnoid cysts and
normal arachnoid tissue in that the Na-K-Cl cotranspor-
ter NKCC1 is up-regulated in arachnoid cysts compared
with normal arachnoid [8], and a small subset genes are
differentially expressed in arachnoid cysts compared
with normal arachnoid tissue [5]. The phosphate level in
the CSF is kept lower than in the blood [16], due to
active transport mechanisms in the choroid plexus
epithelia. Higher phosphate concentration in the cyst
fluid could imply that the cyst epithelium is either not,
or is differentially equipped with transport mechanisms
relative to the choroid plexus. There are several lines
of evidence suggesting that co-transporters such as
G L U T 1 ,M C T 1a n dN K C C 1h a v et h ea b i l i t yt ot r a n s -
port water along with their respective substrates, regard-
less of the osmotic gradients [17].
As we have only studied temporal cysts, we cannot
generalize the assumption of an active transport
mechanism to all ACs. For other locations, other fillings
mechanisms may well exist, such as a slit-valve in supra-
cellar cysts [18,19]. In our study, two patients differed
from the others - one with a previous hematoma in
close proximity to the cyst and one being a reoperation.
The protein levels in the cyst fluid from these patients
were significantly higher than in the rest of the study
group. In their study Sandberg et al [11] found that 14
of the 41 patients had markedly higher protein concen-
trations (above 0.5 g/L) in the cysts; four of those had
extreme values such as the ones we observed. The cause
for some cysts to have a marked elevated protein level is
not well understood, but products from previous bleed-
ing in the cyst may be one explanation. Correlation ana-
lysis between protein, ferritin and lactate dehydrogenase
was performed as a statistical control to rule out blood
contamination as a possible explanation of the protein
content in the CSF. The protein concentration of CSF
relative to plasma is about 0.5-1%; a leak of plasma to
the CSF would introduce a large source of error to the
analysis. If the difference in concentration of protein,
lactate dehydrogenase and ferritin was caused by blood
contamination, the correlation should be expected to be
significant and close to 100%. These correlation results
do not show a strong association between assumed
blood contaminants and the findings, thus not support-
ing blood contamination as explaining variable.
A limitation for this study is the small number of
samples. Applied on such a dataset, the T-test is vulner-
able to outliers such as the excluded patient 12 in pro-
tein concentration (outlier plots not shown).
Nonetheless, our results can support reflections around
the filling mechanisms for arachnoid cysts. As far as the
authors know, this is the first publication of AC fluid
analysis matched with CSF from the same patient.
Conclusions
The chemical composition of AC fluid found in this
study does not support an oncotic pressure or valve
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pattern of differences, we postulate that the filling
mechanism for temporal AC is by either a selective or
active transport mechanism or a secretion from the
cyst-lining cells.
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